NCT04214106View on ClinicalTrials.gov

Thiamine Administration and Prevalence of Delirium in the Intensive Care Unit: A Before-after Study

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Delirium
Interventions
DRUG

intravenous Thiamine

patients who received Thiamine,100-500 mg/day for at least one day

Trial Locations (1)

Unknown

Meir medical center Kfar Saba, Kfar Saba

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER

NCT04214106 - Thiamine Administration and Prevalence of Delirium in the Intensive Care Unit: A Before-after Study | Biotech Hunter | Biotech Hunter